These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6824558)

  • 1. The potential therapeutic role of the enantiomers and metabolites of mianserin.
    Pinder RM; Van Delft AM
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):269S-276S. PubMed ID: 6824558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological aspects of mianserin.
    Pinder RM; van Delft AM
    Acta Psychiatr Scand Suppl; 1983; 302():59-71. PubMed ID: 6301219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenoreceptor interactions of the enantiomers and metabolites of mianserin: are they responsible for the antidepressant effect?
    Pinder RM
    Acta Psychiatr Scand Suppl; 1985; 320():1-9. PubMed ID: 2996305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of mianserin and its enantiomers and metabolites on a behavioral screen for antidepressant activity.
    Hand TH; Marek GJ; Seiden LS
    Psychopharmacology (Berl); 1991; 105(4):453-8. PubMed ID: 1771213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postjunctional effects of mianserin and its metabolites on the rat isolated anococcygeus muscle.
    Doggrell SA
    J Pharm Pharmacol; 1985 Feb; 37(2):116-20. PubMed ID: 2858543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]Mianserin: differential labeling of serotonin and histamine receptors in rat brain.
    Peroutka SJ; Snyder SH
    J Pharmacol Exp Ther; 1981 Jan; 216(1):142-8. PubMed ID: 6109019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the enantiomers of mianserin, desmethylmianserin, and 8-hydroxymianserin in the plasma and urine of mianserin-treated patients.
    Eap CB; Powell K; Campus-Souche D; Monney C; Baettig D; Taeschner W; Baumann P
    Chirality; 1994; 6(7):555-63. PubMed ID: 7986669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacology of mianserin, its main metabolites and 6-azamianserin.
    Nickolson VJ; Wieringa JH; van Delft AM
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Apr; 319(1):48-55. PubMed ID: 6287300
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapid down-regulation of S2 serotonin receptors by antidepressants: noradrenergic-serotonergic interactions.
    Helmeste DM
    Life Sci; 1986 Jul; 39(3):223-7. PubMed ID: 3016437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaco-EEG study of 6-azamianserin (ORG 3770): dissociation of EEG and pharmacologic predictors of antidepressant activity.
    Fink M; Irwin P
    Psychopharmacology (Berl); 1982; 78(1):44-8. PubMed ID: 6815696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A stereochemical investigation of the cytotoxicity of mianserin metabolites in vitro.
    Riley RJ; Lambert C; Kitteringham NR; Park BK
    Br J Clin Pharmacol; 1989 Jun; 27(6):823-30. PubMed ID: 2757897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of (+/-)mianserin and its enantiomers on the behavioural hyperactivity of the olfactory-bulbectomized rat.
    Jancsár SM; Leonard BE
    Neuropharmacology; 1984 Sep; 23(9):1065-70. PubMed ID: 6083502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonistic effects of some metabolites and analogues of mianserin on serotonin and alpha 1- and alpha 2-adrenergic receptors in the flexor reflex model in vivo.
    Przegaliński E; Rawłów A; Dohnal-Borak I
    Pol J Pharmacol Pharm; 1986; 38(1):69-75. PubMed ID: 3020532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of thioridazine, an inhibitor of CYP2D6, on the steady-state plasma concentrations of the enantiomers of mianserin and its active metabolite, desmethylmianserin, in depressed Japanese patients.
    Yasui N; Tybring G; Otani K; Mihara K; Suzuki A; Svensson JO; Kaneko S
    Pharmacogenetics; 1997 Oct; 7(5):369-74. PubMed ID: 9352572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1978 Oct; 16(4):273-301. PubMed ID: 359311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mianserin: a decade of scientific development.
    Peet M; Behagel H
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):5S-9S. PubMed ID: 623702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of carbamazepine coadministration on plasma concentrations of the enantiomers of mianserin and of its metabolites.
    Eap CB; Yasui N; Kaneko S; Baumann P; Powell K; Otani K
    Ther Drug Monit; 1999 Apr; 21(2):166-70. PubMed ID: 10217335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in presynaptic alpha-blockade, noradrenaline uptake inhibition, and potential antidepressant activity between (+)- and (-)mianserin.
    Schoemaker H; Berendsen HH; Stevens HJ; Nickolson VJ
    Psychopharmacology (Berl); 1981; 74(2):137-42. PubMed ID: 6115445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin receptor sensitivity after acute and chronic treatment with mianserin.
    Blackshear MA; Sanders-Bush E
    J Pharmacol Exp Ther; 1982 May; 221(2):303-8. PubMed ID: 7077527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between enantiomers of mianserin and ORG3770 at 5-HT3 receptors in cultured mouse neuroblastoma cells.
    Kooyman AR; Zwart R; Vanderheijden PM; Van Hooft JA; Vijverberg HP
    Neuropharmacology; 1994; 33(3-4):501-7. PubMed ID: 7984289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.